AML patients at the extremes of older age derive benefit from VEN-HMA regimen

FHS
May 10, 2024
3:50 am

Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio’s lead programme for AATD can potentially edit the genetic mutation in RNA instead of altering DNA. Credit: MattL_Images / Shutterstock.com. Korro Bio has

July 17, 2023

US Patients Show Cautious Optimism Toward GenAI in Healthcare

What You Should Know: – New research from Bain & Company has revealed an intriguing trend in the healthcare industry: U.S. patients are more comfortable

August 14, 2024

Boston Scientific, Edwards and Dexcom usher in second week of earnings

The second wave of the medtech industry’s latest earnings season arrives this week, with Boston Scientific, Edwards Lifesciences and Dexcom all set to report their

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.